Andrew P. Montgomery

613 total citations · 1 hit paper
24 papers, 395 citations indexed

About

Andrew P. Montgomery is a scholar working on Molecular Biology, Organic Chemistry and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Andrew P. Montgomery has authored 24 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Organic Chemistry and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Andrew P. Montgomery's work include Glycosylation and Glycoproteins Research (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Chemical Synthesis and Analysis (4 papers). Andrew P. Montgomery is often cited by papers focused on Glycosylation and Glycoproteins Research (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Chemical Synthesis and Analysis (4 papers). Andrew P. Montgomery collaborates with scholars based in Australia, United States and Nepal. Andrew P. Montgomery's co-authors include Michael Kassiou, Jonathan J. Danon, Haibo Yu, Danielle Skropeta, S B Rosalki, Xingyong Wang, Lenka Munoz, Bryan W. Day, Marie Ranson and Ariadna Recasens and has published in prestigious journals such as Chemical Reviews, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Andrew P. Montgomery

23 papers receiving 382 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Late-stage Functionalization for Improving Drug-like Molecular Properties

2023 135 citations Andrew P. Montgomery, Jonathan J. Danon et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew P. Montgomery Australia	11	202	181	36	32	31	24	395
Charlie Fehl United States	9	304 1.5×	284 1.6×	46 1.3×	28 0.9×	40 1.3×	16	503
Scott R. Pollack United States	9	189 0.9×	98 0.5×	20 0.6×	47 1.5×	22 0.7×	16	299
Bernat Vidal Spain	20	559 2.8×	238 1.3×	44 1.2×	34 1.1×	39 1.3×	39	773
James C. Lanter United States	18	392 1.9×	180 1.0×	14 0.4×	32 1.0×	26 0.8×	34	584
Zhu-Jun Yao United States	12	173 0.9×	280 1.5×	39 1.1×	53 1.7×	15 0.5×	17	387
Shinobu Honzawa Japan	14	295 1.5×	168 0.9×	12 0.3×	43 1.3×	17 0.5×	30	599
Jianhua Cao China	14	240 1.2×	273 1.5×	34 0.9×	48 1.5×	13 0.4×	24	578
Noel A. Powell United States	17	459 2.3×	309 1.7×	79 2.2×	45 1.4×	32 1.0×	29	751
Jo Alen Belgium	11	118 0.6×	144 0.8×	16 0.4×	21 0.7×	32 1.0×	17	395

Countries citing papers authored by Andrew P. Montgomery

Since Specialization

Citations

This map shows the geographic impact of Andrew P. Montgomery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew P. Montgomery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew P. Montgomery more than expected).

Fields of papers citing papers by Andrew P. Montgomery

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew P. Montgomery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew P. Montgomery. The network helps show where Andrew P. Montgomery may publish in the future.

Co-authorship network of co-authors of Andrew P. Montgomery

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew P. Montgomery. A scholar is included among the top collaborators of Andrew P. Montgomery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew P. Montgomery. Andrew P. Montgomery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Montgomery, Andrew P., et al.. (2025). Optimised synthesis of florzolotau and its fluorine-18 radiolabelling precursor. Tetrahedron. 179. 134649–134649.

Montgomery, Andrew P., et al.. (2025). The adamantane scaffold: Beyond a lipophilic moiety. European Journal of Medicinal Chemistry. 291. 117592–117592. 7 indexed citations

Dhar, K.L., et al.. (2024). Enhancing CNS mitophagy: drug development and disease-relevant models. Trends in Pharmacological Sciences. 45(11). 982–996. 4 indexed citations

Montgomery, Andrew P., et al.. (2024). Structure-based drug design for TSPO: Challenges and opportunities. Biochimie. 224. 41–50. 2 indexed citations

Savage, G. Paul, et al.. (2024). Fragment-based drug discovery for disorders of the central nervous system: designing better drugs piece by piece. Frontiers in Chemistry. 12. 1379518–1379518. 11 indexed citations

Montgomery, Andrew P., et al.. (2024). Unlocking therapeutic potential: the role of adamantane in drug discovery. Australian Journal of Chemistry. 77(8). 7 indexed citations

Montgomery, Andrew P., et al.. (2024). Synthesis of α‐Hydroxy‐1,2,3‐Triazole‐linked Sialyltransferase Inhibitors and Evaluation of Selectivity Towards ST3GAL1, ST6GAL1 and ST8SIA2. ChemMedChem. 19(16). e202400088–e202400088. 2 indexed citations

Mardon, Karine, Andrew P. Montgomery, Rajiv Bhalla, et al.. (2023). Synthesis and Preclinical Evaluation of Fluorinated 5-Azaindoles as CB2 PET Radioligands. ACS Chemical Neuroscience. 14(16). 2902–2921. 1 indexed citations

Montgomery, Andrew P., et al.. (2022). Strategies for targeting the P2Y12 receptor in the central nervous system. Bioorganic & Medicinal Chemistry Letters. 71. 128837–128837. 7 indexed citations

10.

Montgomery, Andrew P., et al.. (2021). Synthesis and biological evaluation of selective phosphonate-bearing 1,2,3-triazole-linked sialyltransferase inhibitors. RSC Medicinal Chemistry. 12(10). 1680–1689. 7 indexed citations

11.

Montgomery, Andrew P., et al.. (2021). DYRK1A Negatively Regulates CDK5-SOX2 Pathway and Self-Renewal of Glioblastoma Stem Cells. International Journal of Molecular Sciences. 22(8). 4011–4011. 18 indexed citations

12.

Skropeta, Danielle, et al.. (2021). Sialyltransferase Inhibitors as Potential Anti-Cancer Agents*. Australian Journal of Chemistry. 74(11). 758–766. 4 indexed citations

13.

Moir, Michael, et al.. (2020). The discovery of a potent and selective pyrazolo-[2,3-e]-[1,2,4]-triazine cannabinoid type 2 receptor agonist. European Journal of Medicinal Chemistry. 210. 113087–113087. 3 indexed citations

14.

Montgomery, Andrew P., et al.. (2020). Design, synthesis and evaluation of carbamate-linked uridyl-based inhibitors of human ST6Gal I. Bioorganic & Medicinal Chemistry. 28(14). 115561–115561. 16 indexed citations

15.

Werry, Eryn L., Jonathan J. Danon, Andrew P. Montgomery, et al.. (2020). Tricyclic heterocycles display diverse sensitivity to the A147T TSPO polymorphism. European Journal of Medicinal Chemistry. 207. 112725–112725. 8 indexed citations

16.

Moir, Michael, Rochelle Boyd, Hendra Gunosewoyo, et al.. (2019). Synthesis and evaluation of various heteroaromatic benzamides as analogues of –ylidene-benzamide cannabinoid type 2 receptor agonists. Tetrahedron Letters. 60(36). 151019–151019. 4 indexed citations

17.

Montgomery, Andrew P., Danielle Skropeta, & Haibo Yu. (2017). Transition state-based ST6Gal I inhibitors: Mimicking the phosphodiester linkage with a triazole or carbamate through an enthalpy-entropy compensation. Scientific Reports. 7(1). 14428–14428. 21 indexed citations

18.

Montgomery, Andrew P., et al.. (2017). Computational Glycobiology: Mechanistic Studies of Carbohydrate-Active Enzymes and Implication for Inhibitor Design. Advances in protein chemistry and structural biology. 109. 25–76. 29 indexed citations

19.

Montgomery, Andrew P., et al.. (2017). Computer‐aided design of human sialyltransferase inhibitors of hST8Sia III. Journal of Molecular Recognition. 31(2). 10 indexed citations

20.

Montgomery, Andrew P., et al.. (2015). Computational characterisation of the interactions between human ST6Gal I and transition-state analogue inhibitors: insights for inhibitor design. Journal of Molecular Recognition. 29(5). 210–222. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact